Skip to main content

Traditions of Antihypertensive Therapy in Different Countries

  • Chapter
Pharmacology of Antihypertensive Therapeutics

Abstract

The therapy of hypertension has evolved over the past 50 years from the short-term care of a small number of hospitalized patients with severely elevated blood pressure and organ damage to a major community health problem involving a substantial proportion of the population with mild to moderate hypertension. In the beginning, severe side effects and toxicity of antihypertensive agents were accepted by patients and doctors as the price that had to be paid for this lifesaving therapy. The results of recent therapeutic trials show the benefits of antihypertensive treatment for mild to moderate hypertension. This has changed the attitudes towards treatment. The aim of modern antihypertensive therapy is the reduction of the risk of cardiovascular disease. The management of hypertensive patients therefore has to include the minimization of other controllable risk factors such as diabetes, hypercholesterolemia, alcohol, and cigarette smoking. Blood pressure lowering can be achieved not only by pharmacological substances but also by non-drug methods, e. g., reduction of sodium intake, reduction of body weight, reduction of alcohol intake, increased physical activity, and meditation. These methods are part of an antihypertensive strategy with different priorities in the European countries.

Professor Shkhvatsabaya died October 11th, 1988.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

References

  • Antonaccio MJ (ed) (1977) Cardiovascular pharmacology. Raven, New York

    Google Scholar 

  • Birkenhäger WH, Reid JL (1984) Clinical pharmacology of antihypertensive drugs. In: Doyle AE (ed) Handbook of hypertension. Elsevier, Amsterdam

    Google Scholar 

  • Bundesverband der Pharmazeutischen Industrie (1986) Basisdaten des Gesundheitwesens 1985/86. Bundesverband der Pharmazeutischen Industrie, Frankfurt

    Google Scholar 

  • Davies DS, Reid JL (eds) (1975) Central action of drugs in blood pressure regulation. Pitman, London

    Google Scholar 

  • Doyle AE, Beam AG (eds) (1984) Hypertension and the angiotensin system. Raven,New York

    Google Scholar 

  • Drayer JIM, Lowenthal DT, Weber MA (eds) (1987) Drug therapy in hypertension. Dekker, New York

    Google Scholar 

  • Ganten D, Ritz E (eds) (1985) Lehrbuch der Hypertonie. Schattauer, Stuttgart

    Google Scholar 

  • Genest J, Kuchel O, Hamet P, Cantin M (eds) (1983) Hypertension. McGraw-Hill, New York

    Google Scholar 

  • Gessler U (ed) (1978) Differentialdiagnose und Therapie der Hypertonie. Aesopus, Lugano

    Google Scholar 

  • Kaufmann W, Bonner G, Lang R, Meurer KA (eds) (1986) Primary hypertension. Springer, Berlin Heidelberg New york

    Google Scholar 

  • Kobinger W, Ahlquist RP (eds) (1984) Alpha and beta adrenoceptors and the cardiovascular system. Excerpta Medica, Amsterdam

    Google Scholar 

  • McMahon FG (ed) (1978) Management of essential hypertension. Futura, New York

    Google Scholar 

  • Rosenthal J (ed) (1986) Arterielle Hypertonie. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Stumpe KO (ed) (1983) Therapie mit Antihypertensiva. Springer, Berlin Heidelberg New York

    Google Scholar 

References

  • Baksaas I (1984) Patterns in drug utilization—national and international aspects: Antihypertensive drugs. Acta Med Scand [Suppl] 683: 59–66

    CAS  Google Scholar 

  • Griffiths K, McDevitt DG, Andrew M, Baksaas I, Helgeland A, Jervell J, Lunde PKM, et al. (1986) Therapeutic traditions in Northern Ireland, Norway and Sweden. II. Hypertension. Eur J Clin Pharmacol 30: 521–525

    Google Scholar 

  • Nordic Council on Medicines (1979) Nordic statistics on medicines 1975–1977. Nordic Council on Medicines, Helsinki

    Google Scholar 

  • Nordic Council on Medicines (1982) Nordic statistics on medicines 1978–1980. Nordic Council on Medicines, Uppsala

    Google Scholar 

  • Nordic Council on Medicines (1986) Nordic statistics on medicines 1981–1983. Nordic Council on Medicines, Uppsala

    Google Scholar 

  • Swedish Statistics on Medicines (1986) Diagnosis and therapy survey. Apoteksbolaget, Stockholm

    Google Scholar 

  • Waaler HT, Hjort PF (1982) The consumption of blood pressure lowering drugs in the Nordic countries. In: Nordic Council on Medicines (ed) Nordic statistics on medicines 1978–1980. Nordic Council on Medicines, Uppsala, pp 195–215 (NLN publication no 8 )

    Google Scholar 

  • Yusuf S, Peto R, Lewis J, Collins R, Sleight P (1985) Beta-blockade during and after myocardial infarction: An overview of the randomized trials. Prog Cardiovasc Dis 5: 335–371

    Google Scholar 

References

  • Barlow RB, Ing HR (1948) Curare-like action of polymethylene bisquarternary ammonium salts. Nature 161: 718

    Article  PubMed  CAS  Google Scholar 

  • Beilin LJ (1988) Epitaph to essential hypertension: a preventable disorder of known aetiology? J Hypertens 6: 85–94

    Article  PubMed  CAS  Google Scholar 

  • Black J (1988) Beta-blockers in clinical practice. Livingstone, Edinburgh, pp v–vii

    Google Scholar 

  • Bright R (1827) Reports of medical cases, selected with a view of illustrating the symptoms and cure of diseases by a reference to morbid anatomy. Longman, London

    Google Scholar 

  • Bright R (1836) Tabular view of the morbid appearances in 100 cases connected with albuminous urine. With observations. Guy’s Hosp Rep 1: 380–392

    Google Scholar 

  • Cameron HA, Ramsay LE (1984) The lupus syndrome induced by hydralazine: a common complication with low-dose treatment. Br Med J 289: 410–412

    Article  CAS  Google Scholar 

  • Cranston WI, Juel-Jensen BE, Semmence AM, Handfield-Jones RPC, Forbes JA, Mutch LMM (1963) Effects of oral diuretics on raised arterial pressure. Lancet 2:966–970 Cruickshank JM, Prichard BNC (1988) Beta-blockers in clinical practice. Livingstone, Edinburgh, pp 3–8

    Google Scholar 

  • Dollery C (1987) Jubilee editorial: hypertension. Br Heart J 58: 179–184

    Article  PubMed  CAS  Google Scholar 

  • Leishman A WD (1959) Hypertension treated and untreated: a study of 400 cases. Br Med J 1: 1361–1368

    Article  PubMed  CAS  Google Scholar 

  • McAreavey D, Ramsay LE, Latham L, McLaren AD, Lorimer AR, Reid JL, Robertson JIS, et al. (1984) “Third Drug” trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta-blocker plus thiazide diuretic. Br Med J 288:106–111

    Google Scholar 

  • McMichael J (1952) The management of hypertension. Br Med J 1: 933–938

    Article  PubMed  CAS  Google Scholar 

  • Medical Research Council Working Party (1981) Adverse reactions to bendrofluazide and propranolol following treatment of mild hypertension. Lancet 2: 539–543

    Google Scholar 

  • Medical Research Council Working Party (1983) Ventricular extrasystoles during thiazide treatment: substudy of the MRC Mild Hypertension Trial. Br Med J 287: 1249–1253

    Article  Google Scholar 

  • Medical Research Council Working Party (1985) MRC Trial of Treatment of Mild

    Google Scholar 

  • Hypertension: principal results. Br Med J 291:97–104

    Google Scholar 

  • Paton WD, Zaimis E (1948) Curare-like action of polymethylene bis-quarternary salts. Nature 161: 718

    Article  CAS  Google Scholar 

  • Perry HM, Schroeder HA (1954) A syndrome simulating collagen disease caused by 1-hydrazino-phthaline (apresoline). JAMA 154: 670–673.

    Google Scholar 

  • Pickering GW (1968) High blood pressure, 2nd edn. J amp; A Churchill, London

    Google Scholar 

  • Piatt R (1954) Hypertensive retinopathy and its medical treatment. Q J Med 23: 441–449

    Google Scholar 

  • Piatt R, Sears HTN (1956) Reserpine in severe hypertension. Lancet 1: 401–403

    Google Scholar 

  • Prichard BN (1964) Hypotensive action of pronethalol. Br Med J 1: 1227–1228

    Article  PubMed  CAS  Google Scholar 

References

  • Ramsay LE (1985) Mild hypertension: treat patients, not populations. J Hypertens 3: 449–455

    Article  PubMed  CAS  Google Scholar 

  • Robertson JIS (1987) The large studies in hypertension: what have they shown? Br J Clin Pharmacol 24:3–14 S

    Google Scholar 

  • Robertson JIS, Ball SG (1989) Hypertension. In: Julian DG, Poole-Wilson PW, Fox K, Camm AJ, Hall R (eds) Diseases of the heart. Baillière Tindall, London 1227–1292

    Google Scholar 

  • Rosenheim ML (1954) The treatment of severe hypertension. Br Med J 2: 1181–1193

    Article  PubMed  CAS  Google Scholar 

  • Smirk FH (1957) High arterial pressure. Blackwell, Oxford, pp 532–535

    Google Scholar 

  • Swales JD (1985) Piatt versus Pickering: an episode in recent medical history. Keynes/ British Medical Association, London

    Google Scholar 

  • Swales JD (1988) Non-pharmacological antihypertensive therapy. Eur Heart J [Suppl Gl 9: 45–52

    Google Scholar 

  • Swales JD, Ramsay LE, Coope J, Pocock S, Robertson JIS, Shafer J, Sever P (1989) Treatment of mild hypertension: Recommendations of the British Hypertension Society. Br Med J 298: 694–698

    Google Scholar 

  • Weber MA (1987) Automatic blood pressure recorders and 24 hour monitoring. Curr Opin Cardiol 2: 748–757

    Article  Google Scholar 

  • Alderman MH (1980) Mild hypertension: new light on an old clinical controversy. Am J Med 69: 653–655

    Article  PubMed  CAS  Google Scholar 

  • Anonymous (1974) Drugs for hypertension. Med Lett 16: 65–68

    Google Scholar 

  • Anonymous (1977) Drugs for hypertension. Med Lett 19: 21–24

    Google Scholar 

  • Anonymous (1984) Drugs for hypertension. Med Lett 26: 107–112

    Google Scholar 

  • Anonymous (1987) Drugs for hypertension. Med Lett 29: 1–6

    Google Scholar 

  • Cloher TP, Whelton PK (1986) Physician approach to the recognition and initial management of hypertension: results of a statewide survey of Maryland physicians. Arch Intern Med 146: 529–533

    Article  PubMed  CAS  Google Scholar 

  • Davidson RA, Meuleman JR (1986) Initial treatment of hypertension: a questionnaire survey. J Clin Hypertens 4: 339–345

    Google Scholar 

  • Dustan HP (1987) Rational therapies for hypertension: is step 1 of stepped care archaic? Circulation 75: 96–100

    Article  PubMed  CAS  Google Scholar 

  • Dzau VJ (1987) Evolution of the clinical management of hypertension: emerging role of “specific” vasodilators as initial therapy. Am J Med [Suppl 1A] 82: 36–43

    Article  CAS  Google Scholar 

  • Freis ED (1982) Should mild hypertension be treated? N Engl J Med 307: 306–309

    Article  PubMed  CAS  Google Scholar 

  • Graves J (1987) Frequent-flyer programs for drug prescribing. N Engl J Med 317: 252

    PubMed  CAS  Google Scholar 

  • Guttmacher S, Teitelman M, Chapin G, Garbowski G, Schnall P (1981) Ethics and preventive medicine: the case of borderline hypertension. Hastings Center Rep 11: 12–20

    Article  CAS  Google Scholar 

  • Hart JT (1983) The practitioner’s view. In: Gross F, Strasser T (eds) Mild hypertension: recent advances. Raven, New York, pp 365–374

    Google Scholar 

  • IMS America (1986) National disease and therapeutic index. Ambler, Pennsylvania

    Google Scholar 

  • Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1977) Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: a cooperative study. JAMA 237: 255–261

    Article  Google Scholar 

  • Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1980) The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 140: 1280–1285

    Google Scholar 

  • Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1984) The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 144: 1045–1057

    Google Scholar 

  • Joint National Committee on Detection, Evaluation, and Treatment of High Blood

    Google Scholar 

  • Pressure (1988) The 1988 report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 148: 1023–1038

    Article  Google Scholar 

  • Kaplan NM (1981) Whom to treat: the dilemma of mild hypertension. Am Heart J 101: 867–870

    Article  PubMed  CAS  Google Scholar 

  • Kaplan NM (1986a) Treatment of hypertension: drug therapy. In: Kaplan NM (ed) Clinical hypertension, 4th edn. Williams and Wilkin, Baltimore, pp 180–272

    Google Scholar 

  • Kaplan NM (1986b) Hypertension in the population at large. In: Kaplan NM (ed) Clinical hypertension, 4th edn. Williams and Wilkins, Baltimore, pp 1–28

    Google Scholar 

  • Kaplan NM (1987) Misdiagnosis of systemic hypertension and recommendations for improvement. Am J Cardiol 80: 1383–1386

    Article  Google Scholar 

  • Koch H (1987) Highlights of drug utilization. In: National Center for Health Statistics (ed) Office Practice National Ambulatory Medical Care Survey, 1985. Public Health Service, Hyattville (Vital and Health Statistic no 134; DHHS publ no (PHS) 87–1250 )

    Google Scholar 

  • Kosecoff J, Fink A, Brook RH, et al. (1985) General medical care and the education of internists in university hospitals: an evaluation of the Teaching Hospital General Medicine Group Practice Program. Ann Intern Med 102: 250–257

    PubMed  CAS  Google Scholar 

  • Krakoff LR, Phillips RA, Eison HB (1987) New directions for hypertenion therapy. Compr Ther 13: 61–68

    PubMed  CAS  Google Scholar 

  • Laragh JH (1973) Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med 55: 261–274

    Article  PubMed  CAS  Google Scholar 

  • Rowland M, Roberts J (1982) Advance data from Vital and Health Statistics no 84. Public Health Services, Washington

    Google Scholar 

  • WHO Drug Utilization Research Group (DURG) (1986) Therapeutic traditions in Northern Ireland, Norway and Sweden. II. Hypertension. Eur J Clin Pharmacol 30: 521–525

    Article  Google Scholar 

  • Zusman RM (1986) Alternatives to traditional antihypertensive therapy. Hypertension 8: 837–842

    PubMed  CAS  Google Scholar 

  • Achutti A, Medeiros AMB (1985) Hipertensâo arterial no Rio Grande do Sul. Bol Saude 12: 2–72

    Google Scholar 

  • Achutti A, Costa E, Fischman A, Bassanesi S, Klein C (1987) Epidemiological survey on arterial pressure supporting preventing health program ( Abstr ). Rev Med Chile 109: 435

    Google Scholar 

  • Debert-Ribeiro MB, Ribeiro AB, Stabile Neto C, Chavess CC, Kater CE, lunes M, Saragoça MAS, et al. (1981) Hypertension and economic activities in Sâo Paulo, Brazil. Hypertension [Suppl 2] 3:11-233–11-237

    Google Scholar 

  • Debert-Ribeiro MB, Ribeiro AB, Stabile Neto C, Ançâo MS, Saragoça MAS, Ramos OL, lunes M, et al. (1982) Prevalencia da hipertensâo na força de trabalho da Grande Sâo Paulo: Influencia de idade, sexo e grupo etnico. Rev Assoc Med Bras 28: 209–215

    Google Scholar 

  • International Marketing Service (1981–1987) The pharmaceutical market of Brasil. International Marketing Service, ZUG

    Google Scholar 

  • Ribeiro AB, Kohlmann O Jr, Marson O, Zanella MT, Ramos OL (1988) Hypertension: A major public health problem in Brazil. Drugs, (in press)

    Google Scholar 

References

  • Aivazyan TA, Zaitsev VP, Yurenev AP (1987) Results of relaxation therapy application in essential hypertension. Kardiologiia 8: 34–36

    Google Scholar 

  • Akuno T, Kondo K, Suzuki H, Saruta T (1980) Effects of prostaglandins E2, I2 and F2, arachidonic acid and undomethacin on pressor responses to norepinephrine in conscious rats. Prostaglandins 19: 855–864

    Article  Google Scholar 

  • Besseghir K (1985) Renal tubular action of prostaglandin E2 on water and electrolyte excretion in the nonanesthetized chicken. J Pharmacol Exp Ther 233: 823–829

    PubMed  CAS  Google Scholar 

  • Britov AN (1984) Control of arterial hypertension at the population level (in Russian). Klin Med (Mosk) 9: 43–49

    Google Scholar 

  • Fabre L, Valloton MB (1983) Prostaglandines et pression arterielle. Schweiz Med Wochenschr 113: 1042–1049

    Google Scholar 

  • Gifford RW, Tarazi RC (1978) Resistant hypertension: diagnosis and treatment. Ann Intern Med 88: 661–665

    PubMed  Google Scholar 

  • Kutsenko AL, Legkonogov AV (1987) Hypotensive effect of plasmapheresis in patients with severe symptomatic arterial hypertension due to renal disease (in Russian). Bull VKNC AMN USSR 1: 87–90

    Google Scholar 

  • Lonigro AJ, Terragno NA, Maliket KU, et al. (1973) Differential inhibition by prostaglandins of the renal action of pressor stimuli. Prostaglandins 3: 595–606

    Article  PubMed  CAS  Google Scholar 

  • McGiff JC (1981) Prostaglandins, prostacyclin and thromboxanes. Annu Rev Pharmacol Toxicol 21: 479–509

    Article  PubMed  CAS  Google Scholar 

  • Nakano J, Chang A, Fisher R (1973) Effect of prostaglandins El5 E2, Ai, A2 and F2 on canine arterial blood flow, cerebrospinal fluid pressure and intraocular pressure. J Neurosurg 38: 32–39

    Article  PubMed  CAS  Google Scholar 

  • Nekrasova AA, Dzhusipov AK, Shkhvatsabaya IK (1982) Use of prostaglandine E2 for the treatment of essential hypertension with high blood pressure levels (in Russian). Kardiologiia 9: 37–41

    Google Scholar 

  • Nekrasova AA, Dzhusipov AK, Chernova NA, Uchitel IA, Akhmetov MA (1984) Change of endocrine renal function in patients with essential hypertension combined with stable hypertension under the effect of PGE infusions (in Russian). Ter Arkh 7: 89–93

    Google Scholar 

  • Nekrasova AA, Suvorov YI, Chernova NA, et al. (1986) Water-salt metabolism in patients with stable essential hypertension and principles of diuretic treatment (in Russian). Kardiologiia 1: 27–34

    Google Scholar 

  • Study Group of the All–Union Cooperative Program on Arterial Hypertension Prevention (AUCPAHP) (1986) Results of secondary prevention of arterial hypertension (in Russian). Bull VKNC AMN USSR 1: 56–62

    Google Scholar 

  • Chang TS et al. (1978a) Hypotensive action of rhynchophylla alkaloids and rhynchophylline (in Chinese). Nat Med J China 58: 408–501

    CAS  Google Scholar 

  • Chang TS et al. (1978b) Evaluation of the therapeutics effect of rhnchophylla alkaloid on hypertension by both Chinese traditional and western medical methods (in Chinese). Nat Med J China 58: 750–753.

    Google Scholar 

  • Di SD et al. (1987) Study on risk factors for stroke in patients with hypertension (in Chinese). Acta Univ Med Secondae Shanghai 7: 339–342

    Google Scholar 

  • Gao Y et al. (1965) Tetrandrine in hypertension, clinical observation and analysis of efficacy of treatment in 270 cases (in Chinese). Chin J Intern Med 13: 504–507

    Google Scholar 

  • Gong LS et al. (1987b) Survey on present status of antihypertensive therapy in 22 clinics in Shanghai (in Chinese). Shanghai Med J 10: 97–98

    Google Scholar 

  • Lu CQ et al. (1980) Preliminary report on general survey of hypertension of whole China in 1979 (in Chinese). Chin J Cardiol 8: 165–169

    Google Scholar 

  • Mao HY et al. (1982) Rhomotoxin pharmacologic action in lowering blood pressure and slowing heart rate. Chin Med J 95: 311–318

    PubMed  CAS  Google Scholar 

  • Shen JQ, Wang LD (1983) Combined effect of hydrochlorothiazide and atenolol in antihypertensive therapy in 42 patients (in Chinese). Acta Pharmacol Sin 4: 254–258

    CAS  Google Scholar 

  • Shen JQ et al. (1981) Atenolol, a new beta-adrenergic blocking agent in treatment of hypertension, therapeutic effect and hemodynamic changes (in Chinese). Chin J Cardiol 9: 94–98

    CAS  Google Scholar 

  • Shen JQ et al. (1986) Therapeutic effects and echocardiography changes in a long term treatment of essential hypertension with western versus Chinese plus western drugs (in Chinese). Shanghai Med J 9: 501–505

    Google Scholar 

  • Shen JQ et al. (1987) Observation of hemodynamic and echocardiography changes in the treatment of essential hypertension with Clonidine compound (in Chinese). N Drugs Clin Remedies 6: 74–77

    Google Scholar 

  • Wang HM et al. (1986) Clinical observation on severe hypertension treated by intravenous labetalol (in Chinese). Chin J Cardiol 14: 28–30

    CAS  Google Scholar 

  • Wang XM, Zhang WZ (1984) Collaborating action of Captopril combined with diuretics in the treatment of mild and moderate hypertension (in Chinese). N Drugs Clin Remedies 3: 150–152

    Google Scholar 

  • Wang XM, Zhang WZ (1986) Clinical analysis of 48 cases of malignant hypertension (in Chinese). Acta Univ Med Secondae Shanghai 6: 362–363

    Google Scholar 

  • Wu YK (1979) Epidemiology and community control of hypertension, stroke and coronary heart disease in China. Chin Med J 92: 665–670

    PubMed  CAS  Google Scholar 

  • Zhang WZ, Shen JQ (1982) Comparison of hemodynamic changes between atenolol and nifedipine in short term treatment of hypertension (in Chinese). N Drugs Clin Remedies 1: 97–100

    Google Scholar 

  • Zhang WZ et al. (1987) Immediate hemodynamic effects in the treatment of hypertension with nitrendipine (in Chinese). N Drugs Clin Remedies 6: 78–79

    Google Scholar 

  • Zhao LY et al. (1987) An observation of the clinical effects of indapamide on hypertension (in Chinese). Chin J Cardiol 15: 333–337

    CAS  Google Scholar 

  • Zhu YJ et al. (1987) Systolic hypertension in the elderly (in Chinese). Chin J Geriatr 6: 246–247

    Google Scholar 

References

  • Dahl LK (1960) Possible role of salt intake in the development of essential hypertension. In: Bock KD, Cottier PT (eds) Essential hypertension. Springer, Berlin Göttingen Heidelberg p 53

    Google Scholar 

  • Isomura K (1987) An epidemiological study of the relationship between recent changes in the dietary habits of the young and old and cardiovascular disease (in Japanese). In: National Cardiovascular Center (ed) Annual Report of the Research on Cardiovascular Diseases 1986. National Cardiovascular Center, Suita p 550

    Google Scholar 

  • Kagan A, Harris BB, Winkelstein W Jr, Johnson KG, Kato H, Syme SL, Rhoads GG, et al. (1974) Epidemiological studies of coronaty heart disease and stroke in Japanese men living in Japan, Hawaii and California: Demographic, physical, dietary and biochemical characteristics. J Chronic Dis 27: 345–364

    Google Scholar 

  • Ministry of Health and Welfare (1983a) Summary of national survey on circulatory disorders 1980. Report of national survey on circulatory disorders 1980. Japan Heart Foundation, Tokyo, p 17

    Google Scholar 

  • Ministry of Health and Welfare (1983b) Summary of national survey on nutrition 1981 (in Japanese). Rinsho Eiyo 62: 38–42

    Google Scholar 

  • Omae T (1985) Pathophysiology and outcome of hypertensive subjects (in Japanese). J Jpn Soc Intern Med 74: 401–405

    Article  CAS  Google Scholar 

  • Omae T, Ueda K, Kikumura T, Shikata T, Fujii I, Yanai T, Hasuo Y (1981) Cardiovascular deaths among hypertensive subjects of middle to old age: a long-term follow-up study in a Japanese community. In: Onesti G, Kim WE (eds) Hypertension in the young and the old. Grune and Stratton, New York, p 285

    Google Scholar 

  • Omae T. Fukiyama K, Ishii M, Miura Y (1987) Current choice of antihypertensive drugs (in Japanese). Jpn J Hypertens 9: 81–97

    Google Scholar 

  • Owada K (1985) International comparison of mortality, morbidity and risk factors of cardiovascular diseases (in Japanese). In: National Cardiovascular Center (ed) annual Report of the Research on Cardiovascular Diseases 1984. National Cardiovascular Center, Suita p 1

    Google Scholar 

  • Ueda K, Hasuo Y, Kiyohara Y, Wada J, Kawano H, Kato I, Fujii I, et al. (1988) Intracerebral hemorrhage in a Japanese community, Hisayama: incidence, changing pattern during long-term follow-up, and related factors. Stroke 19: 48–52

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lang, R. et al. (1990). Traditions of Antihypertensive Therapy in Different Countries. In: Ganten, D., Mulrow, P.J. (eds) Pharmacology of Antihypertensive Therapeutics. Handbook of Experimental Pharmacology, vol 93 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74209-5_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74209-5_23

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74211-8

  • Online ISBN: 978-3-642-74209-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics